摘要
目的:探讨肾脏巨大血管平滑肌脂肪瘤(angiomyolipoma,AML)彩色多普勒超声及超声造影表现,提高超声对肾脏巨大AML的诊断准确度,为临床诊断和治疗提供可靠依据。方法:分析23例经病理学检查证实为肾脏巨大AML患者的图像特征,包括与肾脏位置关系、形态、大小、边界、内部回声及超声造影增强模式等特征。结果:23例肾脏巨大AML患者,右肾10例,左肾13例(其中2例有2个肿块),共计25个肿块;25个肿块均向肾外生长突出于肾脏轮廓之外,肾皮质和/或集合系统受挤压;20个肿块呈高回声,其中15个呈较为均匀的高回声,5个内部回声不均匀,呈多发斑片状高回声夹杂不规则低回声;3个呈不均匀混杂回声(2个肿块内部出血坏死,1个肿块破裂至肾周血肿);2个呈低回声。8例行超声造影检查,其中3例为“快进慢出”增强模式,5例为“慢进慢出”增强模式。结论:彩色多普勒超声对肾脏巨大AML具有较高的诊断价值,超声造影可以显示肿块血供情况及造影剂灌注模式,尤其对破裂出血肿块具有很高的诊断价值。
Objective:To investigate the color Doppler ultrasound and contrast-enhanced ultrasound findings of renal giant angiomyolipoma(AML)for improving the diagnostic accuracy of renal giant AML,and providing reliable basis for clinical diagnosis and treatment.Methods:A total of 23 cases of renal giant AML confirmed by pathology were analyzed,including relation to renal location,shape,size,boundary,internal echo and contrast agent perfusion mode.Results:There were 25 masses in 23 patients with giant AML of the kidney,including 10 cases in the right kidney and 13 cases in the left kidney(including 2 masses in 2 cases).Twenty masses were hyperechoic,15 of them were homogeneous hyperechoic,5 were heterogeneous,multiple patchy hyperechoic with irregular hypoechoic;3 were heterogeneous mixed echo(2 masses had hemorrhage and necrosis,1 mass ruptured to perirenal hematoma);2 were hypoechoic.8 cases were examined by contrast-enhanced ultrasound,including 3 cases of fast in slow out enhancement mode,5 cases of slow in slow out enhancement mode.Conclusion:Color Doppler ultrasound has a high diagnostic value for renal giant AML.Contrast-enhanced ultrasound can show the blood supply of the tumor and the mode of contrast agent enhancement,especially for ruptured and bleeding masses.
作者
杨杨
徐惠君
陶堃
袁韵
王涛
徐泉
YANG Yang;XU Huijun;TAO Kun;YUAN Yun;WANG Tao;XU Quan(Department of Ultrasound,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230031,Anhui Province,China;Department of Oncology,The First Affiliated Hospital of USTC,Division of Life Sciences and Medicine,University of Science and Technology of China,Hefei 230031,Anhui Province,China)
出处
《肿瘤影像学》
2021年第5期404-409,共6页
Oncoradiology